Pensionfund DSM Netherlands’s United Therapeutics UTHR Stock Holding History

Pensionfund DSM Netherlands’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-22,000	Closed	-$2.47M	–	228
2018 Q1	$2.47M	Buy	+22,000	New	+$2.79M	0.44%	125
2017 Q2	–	Sell	-17,900	Closed	-$2.42M	–	222
2017 Q1	$2.42M	Sell	17,900 -5,100	-22%	-$773K	0.36%	145
2016 Q4	$3.3M	Hold	23,000	–	–	0.48%	91
2016 Q3	$2.72M	Hold	23,000	–	–	0.36%	141
2016 Q2	$2.44M	Hold	23,000	–	–	0.33%	150
2016 Q1	$2.56M	Sell	23,000 -5,000	-18%	-$633K	0.35%	149
2015 Q4	$4.38M	Buy	28,000 +10,000	+56%	+$1.46M	0.6%	54
2015 Q3	$2.36M	Buy	+18,000	New	+$2.89M	0.34%	130

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pensionfund DSM Netherlands's UTHR Position: Q2 2018 in Review

Pensionfund DSM Netherlands sold out of United Therapeutics (UTHR) in Q2 2018, closing a stake of 22,000 shares — an estimated $2.47M sold.

Pensionfund DSM Netherlands first reported a position in UTHR in Q3 2015 and held it in 8 quarters. The position peaked at $4.38M in Q4 2015. 374 funds tracked by Wall St. Rank hold UTHR as of Q2 2018.

Pensionfund DSM Netherlands reported no remaining United Therapeutics position as of Q2 2018 after selling out during the quarter.
Pensionfund DSM Netherlands sold 22,000 United Therapeutics shares in Q2 2018, an estimated $2.47M.
Pensionfund DSM Netherlands first reported a position in United Therapeutics in Q3 2015 and held it in 8 quarters.
Pensionfund DSM Netherlands's United Therapeutics position peaked at $4.38M in Q4 2015.
374 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2018.

Based on Pensionfund DSM Netherlands's 13F filing for Q2 2018, filed 2 Jul 2018.